The "GATA2 Full-Length Gene Sequencing Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the GATA2 gene, which are associated with a spectrum of hematologic conditions and disorders. This gene plays a crucial role in the development and function of the immune system, and mutations can lead to conditions such as chronic neutropenia, MonoMac syndrome, myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML). These disorders are characterized by a range of symptoms, including increased susceptibility to infections, anemia, and a higher risk of developing leukemia.
The test, priced at 2800 AED, involves sequencing the entire length of the GATA2 gene to pinpoint specific genetic alterations. This comprehensive approach ensures a high level of accuracy in diagnosis, which is critical for the effective management and treatment of the associated conditions. Early detection through this genetic testing allows for timely intervention, potentially improving patient outcomes.
Performed at the state-of-the-art facilities of DNA Labs UAE, the test is conducted under stringent quality controls, ensuring reliable and precise results. For individuals presenting symptoms indicative of the related disorders, or those with a family history of such conditions, the GATA2 Full-Length Gene Sequencing Test offers a valuable diagnostic tool, aiding in the development of personalized treatment plans.
The "Microarray 750K AFCVSCBPOCPB Test" offered by DNA Labs UAE is a comprehensive genetic analysis tool designed to screen for a wide range of genetic conditions, variations, and traits. This advanced microarray test examines over 750,000 specific markers across the human genome, making it an invaluable resource for detailed genetic research, personalized medicine, and in-depth health risk assessments.
At a cost of 4800 AED, the test provides a cost-effective solution for individuals seeking an extensive understanding of their genetic makeup. It is particularly useful for identifying genetic predispositions to certain health conditions, understanding inherited traits, and tailoring personal health and wellness strategies accordingly.
DNA Labs UAE, a leading facility in genetic testing, employs state-of-the-art technology and highly skilled professionals to conduct the Microarray 750K AFCVSCBPOCPB Test. The lab ensures accuracy, confidentiality, and timely delivery of results, making it a trusted choice for individuals and healthcare providers seeking comprehensive genetic insights.
The HLA Pre-Transplant Workup Panel 2 Test is a critical diagnostic tool used in the preparation for organ and tissue transplantation. This comprehensive test is performed to ensure compatibility between the donor and recipient, thereby reducing the risk of transplant rejection. HLA, or Human Leukocyte Antigen, testing is crucial for identifying the specific antigens on the surface of cells that can trigger an immune response in the recipient's body.
Performed at DNA Labs UAE, a facility renowned for its advanced diagnostic services, the HLA Pre-Transplant Workup Panel 2 Test involves a series of sophisticated assays to analyze the HLA genes of both donor and recipient. This test is pivotal in matching organ donors with recipients in transplant medicine, making it an indispensable part of the pre-transplant evaluation process.
The cost of the HLA Pre-Transplant Workup Panel 2 Test at DNA Labs UAE is 4800 AED. This investment is crucial for the success of transplant procedures, as it significantly increases the chances of compatibility, thereby enhancing the long-term outcomes for transplant recipients. With its state-of-the-art technology and expert team, DNA Labs UAE ensures precise and reliable results, providing a solid foundation for successful transplantation.
The "Nx Gen Sequencing Albinism Test" is a state-of-the-art genetic test offered by DNA Labs UAE, designed to accurately diagnose albinism, a group of genetic disorders characterized by a lack of melanin pigment in the skin, hair, and eyes. Utilizing Next Generation Sequencing (NGS) technology, this test can identify mutations in the specific genes known to cause albinism, providing a comprehensive analysis of the genetic markers associated with this condition. With a cost of 5730 AED, the test offers a reliable solution for individuals seeking a definitive diagnosis, enabling them to understand their condition better and seek appropriate treatment and management. DNA Labs UAE ensures precision, confidentiality, and support throughout the testing process, making it a trusted choice for genetic testing in the region.
Leber Congenital Amaurosis (LCA) is a genetic disorder that leads to severe vision loss or blindness at birth or within the first few months of life. To provide a precise diagnosis and potentially guide treatment options, the Nx Gen Sequencing Leber Congenital Amaurosis Test is offered by DNA Labs UAE. This advanced genetic test utilizes next-generation sequencing (NGS) technology to analyze the specific genes known to be associated with LCA, allowing for the identification of mutations that may be responsible for the condition in affected individuals.
The test is priced at 5730 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, which is equipped with the latest in genetic testing technology. By pinpointing the exact genetic mutations present, this test not only facilitates an accurate diagnosis but also helps in understanding the inheritance patterns of the disorder, which is crucial for affected families considering future pregnancies. Moreover, with the rapid advancements in gene therapy and other treatments, identifying the specific genetic cause of LCA can open up new avenues for personalized treatment plans.
The Nx Gen Sequencing Microphthalmia Anophthalmia Coloboma Spectrum Test is a comprehensive genetic screening designed to diagnose conditions within the spectrum of eye development disorders, including microphthalmia (small eye), anophthalmia (absence of one or both eyes), and coloboma (missing pieces of tissue in structures that form the eye). Utilizing next-generation sequencing (NGS) technology, this test can identify mutations in the genes known to be associated with these conditions, offering insights into the genetic cause of the disorder in affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test aims to provide crucial information for diagnosis, management, and genetic counseling for families affected by these conditions. With a cost of 5730 AED, the test represents an investment in understanding the genetic underpinnings of these eye development disorders, potentially guiding treatment options and supporting research into new therapies. This test is particularly valuable for families seeking answers about the genetic basis of these conditions and for healthcare professionals involved in the care of patients with visual impairments due to developmental eye disorders.
The Nx Gen Sequencing Ophthalmoplegia Test is a cutting-edge diagnostic procedure available at DNA Labs UAE, designed to identify genetic markers associated with ophthalmoplegia, a condition characterized by weakness or paralysis of the eye muscles. This sophisticated test leverages Next Generation Sequencing (NGS) technology to analyze multiple genes simultaneously, providing comprehensive insights into the genetic underpinnings of this condition. With a cost of 5730 AED, the test offers a thorough examination of the patient's DNA to pinpoint mutations that could lead to ophthalmoplegia, aiding in the accurate diagnosis and facilitating tailored treatment plans for affected individuals. By choosing DNA Labs UAE for this test, patients can expect reliable, precise, and swift genetic analysis in their quest for answers and management strategies for ophthalmoplegia.
The "Nx Gen Sequencing Retinitis Pigmentosa Test" offered by DNA Labs UAE represents a cutting-edge genetic screening aimed at diagnosing Retinitis Pigmentosa (RP), a group of genetic disorders that cause retinal degeneration and, consequently, vision loss. This test leverages Next Generation Sequencing (NGS) technology to meticulously analyze the genetic makeup of individuals, identifying mutations in the genes known to be associated with RP. By doing so, it enables early detection and a better understanding of the specific type of RP a patient might have, facilitating personalized management and treatment plans.
Priced at 5730 AED, the test is a significant investment in personal health, particularly for those with a family history of Retinitis Pigmentosa or related symptoms. Conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services, clients can expect a thorough and reliable diagnostic process. This test is especially valuable for families seeking clarity on their genetic health, enabling informed decisions about future generations' risk of inheriting RP.
The Nx Gen Sequencing Usher Syndrome Test is a cutting-edge diagnostic tool available at DNA Labs UAE, designed to accurately identify genetic markers associated with Usher Syndrome. Usher Syndrome is a rare genetic disorder that leads to a combination of hearing loss and visual impairment, significantly affecting the quality of life. This test utilizes next-generation sequencing technology to analyze the patient's DNA, targeting specific genes known to be linked with the syndrome, providing a comprehensive understanding of the genetic mutations present.
At a cost of 5730 AED, the test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high precision and reliability. It is particularly valuable for individuals with a family history of Usher Syndrome or those exhibiting symptoms, offering crucial insights for early intervention and management strategies. By opting for this advanced genetic test, patients and healthcare providers can make informed decisions regarding future healthcare plans, potentially mitigating the progression of symptoms associated with Usher Syndrome.
The Oncopro Colorectal Cancer Screen is a cutting-edge diagnostic test designed to detect circulating tumor cells (CTCs) in the bloodstream, which are indicative of colorectal cancer. This non-invasive test offers a promising approach for early detection of colorectal cancer, potentially even before symptoms appear or when the cancer is in its initial stages. Circulating tumor cells are cancer cells that have detached from the primary tumor and circulate in the bloodstream, aiming to form metastases in other organs. The presence of these cells can be a crucial indicator of the spread of cancer, making their detection a valuable tool in cancer management and prognosis.
Performed at DNA Labs UAE, a leading facility in medical diagnostics, the test leverages advanced technology to accurately identify and quantify circulating tumor cells. This innovative approach not only aids in the early detection of colorectal cancer but also helps in monitoring the disease's progression and evaluating the effectiveness of ongoing treatments. It is a significant advancement in the realm of personalized medicine, allowing for tailored treatment strategies based on the patient's specific cancer profile.
The test cost is set at 5730 AED, reflecting the sophisticated technology and expertise required to conduct this advanced diagnostic procedure. While the cost might seem high, the value it provides in terms of early detection, personalized treatment plans, and potentially improved outcomes can be immeasurable for individuals at risk of or battling colorectal cancer. Early detection through tests like the Oncopro Colorectal Cancer Screen can significantly increase the chances of successful treatment and survival, making it a potentially life-saving investment.
